| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.11 | 0.4 |